Ignite Creation Date:
2025-12-25 @ 2:27 AM
Ignite Modification Date:
2025-12-31 @ 11:21 AM
Study NCT ID:
NCT01331434
Status:
COMPLETED
Last Update Posted:
2018-01-23
First Post:
2011-04-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions
Sponsor:
Roxane Laboratories
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-10
Start Date Type:
None
Primary Completion Date:
2004-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-10
Completion Date Type:
ACTUAL
First Submit Date:
2011-04-06
First Submit QC Date:
None
Study First Post Date:
2011-04-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-19
Last Update Post Date:
2018-01-23
Last Update Post Date Type:
ACTUAL